Impaired copper transport in schizophrenia results in a copper-deficient brain state: A new side to the dysbindin story.

ABSTRACT: Objectives: Several schizophrenia brain regions exhibit decreased dysbindin. Dysbindin modulates copper transport crucial for myelination, monoamine metabolism and cellular homeostasis. Schizophrenia patients (SZP) exhibit increased plasma copper, while copper-decreasing agents produce schizophrenia-like behavioural and pathological abnormalities. Therefore, we sought to determine dysbindin and copper transporter protein expression and copper content in SZP.Methods: We studied the copper-rich substantia nigra (SN) using Western blot and inductively-coupled plasma mass spectrometry. We characterised specific protein domains of copper transporters ATP7A, CTR1, ATP7B and dysbindin isoforms 1?A and 1B/C in SZP (n?=?15) and matched controls (n?=?11), and SN copper content in SZP (n?=?14) and matched controls (n?=?11). As a preliminary investigation, we compared medicated (ON; n?=?11) versus unmedicated SZP (OFF; n?=?4).Results: SZP exhibited increased C terminus, but not N terminus, ATP7A. SZP expressed less transmembrane CTR1 and dysbindin 1B/C than controls. ON exhibited increased C terminus ATP7A protein versus controls. OFF exhibited less N terminus ATP7A protein than controls and ON, suggesting medication-induced rescue of the ATP7A N terminus. SZP exhibited less SN copper content than controls.Conclusions: These results provide the first evidence of disrupted copper transport in schizophrenia SN that appears to result in a copper-deficient state. Furthermore, copper homeostasis may be modulated by specific dysbindin isoforms and antipsychotic treatment.

SUBMITTER: Schoonover KE 

PROVIDER: S-EPMC6424639 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature